Yonatan Malca - 01 Jan 2022 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli , Attorney-in-Fact
Issuer symbol
ENTX
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
4
Filing time
14 Jan 2022, 06:06:45 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Stock Option (right to buy) Award $0 +35,852 $0.000000 35,852 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 35,852 $2.82 Direct F1
transaction ENTX Stock Option (right to buy) Award $0 +107,557 $0.000000 107,557 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 107,557 $2.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022.
F2 The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022.